XSHG
603970
Market cap469mUSD
Oct 09, Last price
11.95CNY
1D
2.31%
1Q
19.14%
IPO
21.94%
Name
Sino-Agri Leading Biosciences Co Ltd
Chart & performance
P/E
18.62
P/S
0.29
EPS
0.64
Div yield, %
3.85%
Shrs. gr., 5y
—
Rev. gr., 5y
11.10%
Revenues
11.24b
+6.08%
Net income
173m
-15.17%
CFO
-73m
L
Dividend
Jun 12, 20260.32 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sino-Agri Leading Biosciences Co.,Ltd, established in 2009 and based in Beijing, China, is an agrochemical company dedicated to the entire lifecycle of crop protection products. The firm engages in the research, development, production, and worldwide distribution of agricultural chemicals. Its product portfolio encompasses a variety of essential solutions, including insecticides, fungicides, and herbicides. This company operates as a subsidiary of the China National Agricultural Means Of Production Group Corporation.
Key people
Yi Su
Chairman of the Board · since 2023
Canmei Li
Chief Financial Officer · since 2023
Baiji Huang
General Manager, Secretary of the Board, Director · since 2023
Mingguang Li
General Manager - Chemical Division, Executive Deputy General Manager, Director · since 2023
Qing Chang
Deputy General Manager · since 2022
Kai Kang
Deputy General Manager, Director
Ying Pu
Director
Jian Yang
Director
Can Zhou
Director · since 2024
Yan Hu
Independent Director · since 2024
Yujiu Liu
Independent Director · since 2023
Aixiang Pan
Independent Director
Xuemin Wu
Independent Director
Headquarters & legal address
北京市西城区宣武门外大街甲1号九层912室
西城区, BJ 100000
CN
西城区, BJ 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||